SCI Member Kudos

Congratulations to SCI Members


ASBMT Award

Robert Negrin, MD, Professor of Medicine and Chief of the Division of Blood and Marrow Transplantation at Stanford Medicine was selected for the 2018 ASBMT E. Donnall Thomas Lecture. The lecture recognizes an eminent physician or scientist, either a clinician or investigator, who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation.


The NAS Award in Molecular Biology

Congratulations to SCI member, Howard Chang, MD, PhD, the Virginia and D. K. Ludwig Professor Of Cancer Genomics, for receiving the 2018 NAS Award in Molecular Biology!  Dr. Chang was awarded with a medal and a $25,000 prize for the discovery of long noncoding RNAs and the invention of genomic technologies.


The V Foundation for Cancer Research 2017 BRCA 1, 2 Research Collaborative Grant Program

Karlene Cimprich, PhD, Professor of Chemical and Systems Biology and, by courtesy, of Chemistry; James Ford, MD, professor of medicine and of genetics and director of the Stanford Clinical Cancer Genetics Program; and Aaron Straight, PhD, Associate Professor of Biochemistry and, by courtesy, of Chemical and Systems Biology were awarded a  $2,100,000 V Foundation research grant for their project entitled - BRCA1/2 Mutation Associated R-Loops: Roles in Genomic Instability and Biomarker Development.


Stand Up To Cancer – LUNGevity – American Lung Association Lung Cancer Award 

SCI members, Maximilian Diehn, MD, PhD,and Ash Alizadeh, MD, PhD, in collaboration with MGH were awarded $2 million by AACR. The aim of the grant is to develop a composite blood-based biomarker to be used in conjunction with imaging for early diagnosis of lung cancer.  Specifically, the researchers will explore combining circulating tumor DNA and circulating tumor cell analyses into an integrated assay.

In addition, SCI member Sanjiv “Sam” Gambhir, MD, PhD, professor and chair of radiology and director of the Canary Center for Cancer Early Detection at Stanford, is the principal Stanford investigator of the SU2C-LUNGevity American Lung Association Lung Cancer Interception Dream Team. This $5 million, four-year project entails creating a molecular atlas of precancerous lung tissue; developing blood tests capable of identifying patients with early lung cancer recurrence and nasal, blood and radiological techniques to discern whether abnormalities on chest imaging are cancerous; and developing tests to determine who is most likely to benefit from particular treatment strategies. 

 


2017 NCI Director's Awards Recipient

Shivaani Kummar, MD, FACP, SCI Translational Oncology Research Program Leader and Director of the Phase I Clinical Research Program, Professor Of Medicine (Oncology) And Of Radiology (Molecular Imaging Program At Stanford) received an NCI Director's Award for Rare Tumor Initiative Team, recognizing her accomplishments "For establishing the Rare Tumors Initiative in the CCR and advancing collaboration and research in the field of rare tumors".   The award was presented at the 2017 NCI Director's Awards Ceremony on October 18, 2017.


The V Foundation - Pediatric Cancer Research Immunology or Immunotherapy Award 

Kara Davis, D.O., Assistant Professor of Pediatrics in the Division of Hematology and Oncology, was awarded a $600,000 V Foundation research grant for her project titled, “Understanding Phenotypic Flexiblity in B-Cell ALL and it impact on CAR-T therapy success”.